Examkin

Soru

Zorluk: KolayPharmacologic Interventions

During a routine follow-up appointment, a 28-year-old female patient reports experiencing persistently low mood, anhedonia, and severe fatigue over the past two months. She recently lost her job and has been struggling to fall asleep. Psychiatric evaluation confirms a new diagnosis of major depressive disorder. Her medical history is notable for a seizure disorder that has been stably managed with carbamazepine for the past five years. When designing a pharmacologic treatment plan, which of the following agents are appropriate and safe choices for this patient? (Select all that apply)

  1. EscitalopramCevap
  2. SertralineCevap
  3. C
    Bupropion
  4. D
    Fluvoxamine
  5. E
    Amitriptyline

Cevap

Escitalopram and Sertraline
Escitalopram and sertraline are selective serotonin reuptake inhibitors (SSRIs) that are considered first-line therapy for major depressive disorder. They are highly appropriate for patients with epilepsy because they do not significantly lower the seizure threshold. Furthermore, they have a very low potential for cytochrome P450 (CYP450) drug interactions, making them ideal and safe choices for a patient already taking carbamazepine.

Adım Adım Çözüm

1
Identify the primary diagnosis and underlying comorbidities.
The patient has new-onset major depressive disorder and a pre-existing seizure disorder managed with carbamazepine.
Comorbidities dictate which psychotropic medications are safe and appropriate to prescribe.
2
Evaluate the safety of antidepressant classes regarding seizure threshold.
Bupropion and tricyclic antidepressants (TCAs) lower the seizure threshold and are contraindicated or relatively contraindicated. SSRIs are generally safe and preferred.
Preventing seizure recurrence is a primary safety concern in patients with epilepsy.
3
Assess for potential pharmacokinetic drug-drug interactions with the patient's current medication.
Carbamazepine is heavily dependent on CYP3A4 for metabolism. Fluvoxamine is a strong CYP inhibitor and must be avoided. Escitalopram and sertraline have minimal CYP450 interactions.
Avoiding toxic accumulation of antiepileptic drugs is essential for patient safety.

Anahtar Kavram

The selection of antidepressants in patients with epilepsy requires avoiding agents that significantly lower the seizure threshold (e.g., bupropion, TCAs) and avoiding agents with strong CYP450 interactions (e.g., fluvoxamine) that could alter antiepileptic drug levels. Escitalopram and sertraline are safe first-line options.
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru